← Back to Search

Acupressure for Rheumatoid Arthritis

N/A
Waitlist Available
Led By Anne Murphy, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Leflunomide (Arava)
Hydroxychloroquine (Plaquenil)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 42
Awards & highlights

Study Summary

This trial is testing if acupressure is a good option for people with rheumatoid arthritis.

Eligible Conditions
  • Rheumatoid Arthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are taking the medication called Leflunomide (brand name Arava).
Select...
You are taking hydroxychloroquine (Plaquenil).
Select...
You are currently taking a medication called sulfasalazine (brand name Azulfadine).
Select...
You are currently taking a medication called tumor necrosis factor inhibitor (TNFi).
Select...
You are taking Etanercept (Enbrel) medication.
Select...
You are currently taking a medication called abatacept (Orencia).
Select...
You have an allergy or known sensitivity to the medication tocilizumab (brand name Actemra).
Select...
You are taking a medication called a Janus kinase inhibitor (JAKi).
Select...
You are taking a medication called tofacitinib (Xeljanz).
Select...
You are currently taking a medication called baricitinib (brand name Olumiant).
Select...
You are taking the medication called Upadacitinib (Rinvoq).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 42
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to day 42 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of self-performed acupressure in patients with RA assessed by Acupressure Tolerability Scale at day 42
Feasibility of self-performed acupressure in patients with RA assessed by the number of sessions completed
Secondary outcome measures
Change in Fibromyalgia Survey Questionnaire
Change in the Patient-Reported Outcomes Measurement Information System Adult Profile (PROMIS-29 +2)

Trial Design

1Treatment groups
Experimental Treatment
Group I: AcupressureExperimental Treatment1 Intervention
The self-acupressure intervention will be delivered using the modified MeTime Acupressure mobile application (App) in addition to in-person or virtual instruction via study staff.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acupressure
2016
N/A
~1430

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,782 Previous Clinical Trials
6,364,643 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
156 Patients Enrolled for Rheumatoid Arthritis
Anne Murphy, MDPrincipal InvestigatorUniversity of Michigan

Media Library

Acupressure Clinical Trial Eligibility Overview. Trial Name: NCT05412121 — N/A
Rheumatoid Arthritis Research Study Groups: Acupressure
Rheumatoid Arthritis Clinical Trial 2023: Acupressure Highlights & Side Effects. Trial Name: NCT05412121 — N/A
Acupressure 2023 Treatment Timeline for Medical Study. Trial Name: NCT05412121 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility criterion for this investigation restricted to individuals aged eighty or younger?

"This medical trial accepts participants aged 25 and over, up to a maximum of 75 years."

Answered by AI

Does my profile fulfill the requirements to join this experiment?

"To qualify for this clinical trial, potential participants should be between 25 and 75 years old, with a diagnosis of rheumatoid arthritis. In total, the research team is looking to recruit 30 individuals."

Answered by AI

How many participants have volunteered for this clinical research?

"Affirmative. Evidenced by the information present on clinicaltrials.gov, this particular trial is still actively recruiting participants. The study was first made available to prospective patients on September 15th 2022 and has since been updated as of October 30th 2022; thus far, thirty individuals are needed from a single medical site for enrollment."

Answered by AI

Are there any open enrollments for this clinical trial presently?

"Indeed, data hosted on clinicaltrials.gov illustrates that this medical study is currently recruiting participants. This trial was initially advertised on September 15th 2022 and underwent its latest update 30 days later. The research effort requires the enrollment of 30 patients from a single site."

Answered by AI
~6 spots leftby Mar 2025